Merck reports better than expected first quarter revenues and discusses what's coming in R&D and the cardiovascular pipeline after several setbacks.
Continue reading "Coming in Monday's "The Pink Sheet" DAILY" »
J&J's abiraterone is cleared for use two months ahead of schedule. Pricing of $5,000 a month is much lower than Dendreon's Provenge, approved for earlier stage disease.
read more
Continue reading "Latest News From "The Pink Sheet" DAILY - Vertex Hep C Drug Gets AC Go-Ahead; Indication Breadth To Be Determined" »
The massive earthquake and tsunami that hit Japan on March 11th has so far resulted in almost 15,000 lives lost and more than 13,000 people are still missing. More than 77,000 houses/buildings were completely destroyed and so many people still live in uncertainty. Our thoughts and prayers remain with those who have suffered in this tragic natural disaster.
In response to the disaster in Japan, New York Pharma Forum will hold a fundraiser, co-hosted by the Consulate-General of Japan in New York, on Wednesday, June 1st, 5:30-8:00 pm, at the Consul General's formal residence in Manhattan.
Continue reading "Japan Fundraiser Hosted By New York Pharma Forum" »
FDA, maybe fearing it has not heard from enough generic drug industry players, schedules another public hearing to solicit comments as user fee negotiations continue.
Continue reading "Coming In Friday's "The Pink Sheet" DAILY - Judge Questions Mylan's Push For Lipitor Generic Exclusivity" »
The Federal Trade Commission is requiring Hikma Pharmaceuticals PLC to divest its generic injectables phenytoin and promethazine to avoid the anticompetitive effect of the company's proposed acquisition of Baxter Healthcare's entire generic injectable pharmaceutical business. Hikma is to sell the two products to X-Gen Pharmaceuticals. In 2009 the injectable anticonvulsant phenytoin had U.S. sales of $1.5 million and generic injectable promethazine, used to treat allergies, nausea and anxiety, had U.S. sales of $17 million.
Continue reading "Coming In Thursday's "The Pink Sheet" DAILY - Hikma To Divest Two Generic Injectables " »
Custom Search
